Mammalian Foregut and Liver Development

哺乳动物前肠和肝脏发育

基本信息

  • 批准号:
    7753860
  • 负责人:
  • 金额:
    $ 40.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-01-01 至 2012-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this proposal is to elucidate the molecular mechanism controlling mammalian foregut and early liver development. The largest exocrine gland in the body the liver produces bile and is the primary site for detoxification. It also performs important endocrine functions by secreting homeostatic blood proteins and regulating glucose levels through glycogen storage. A recent trans-NIH report "Action Plan for Liver Disease Research (2004)" recognized that a better understanding of embryonic liver development would provide important insights into human liver disease and promote our ability to harness embryonic stem cells as a renewable source of tissue for transplantation. The mouse embryonic liver is induced from the ventral foregut endoderm by FGF signals from the cardiac mesoderm. While we increasingly understand the genetic pathways regulating proliferation and differentiation of hepatoblasts after the liver bud has formed, the earlier events linking endoderm patterning to hepatic specification are less clear. In Xenopus we recently determined that differential Wnt/beta-catenin signaling regulates endoderm fates. Our data supports a model where during gastrula and early somite stages secreted Wnt- antagonists in the anterior endoderm establish foregut identity and initiate a molecular cascade leading to liver development. In contrast, the posterior endoderm has high beta-catenin activity, due to Wnt ligands secreted from the lateral/axial mesoderm, which represses foregut fate and promotes intestinal development. We propose to test this hypothesis using mouse genetics and embryonic explants to characterize the underlying molecular mechanism. Moreover, we will investigate whether analogous pathways are important for liver development in humans using endoderm cultures derived from human embryonic stem cells. The results of this proposal will directly impact efforts to generate therapeutically useful endoderm tissue for the treatment of liver disease in humans. Aim 1. Determine if repression of beta-catenin activity in the anterior endoderm is required for foregut and liver development using mouse genetics. Aim 2. Define when beta-catenin needs to be repressed and examine how the temporally distinct Wnt and FGF pathways interact during hepatic development, using mouse embryonic explant cultures. Aim 3. Investigate the role of Wnt signaling in promoting human foregut and liver lineages from HESCs. PUBLIC HEALTH RELEVANCE. The liver is a vital organ providing many essential functions and numerous diseases are so life threatening that liver transplantation is the only option. The differentiation of liver cells from embryonic stem cells is a potentially renewable source of tissue for transplantation. The goal of this proposal is to elucidate the genetic programs controlling embryonic liver development in mice. We will then use this information to recapitulating the key embryonic events in human embryonic stem cells to more effectively generate liver tissue in culture.
描述(由申请人提供):本提案的长期目标是阐明控制哺乳动物前肠和早期肝脏发育的分子机制。肝脏是人体最大的外分泌腺,产生胆汁,是解毒的主要场所。它还通过分泌稳态血液蛋白和通过糖原储存调节葡萄糖水平来执行重要的内分泌功能。最近的一份trans-NIH报告“肝病研究行动计划(2004)”认识到,更好地了解胚胎肝脏发育将为人类肝病提供重要的见解,并促进我们利用胚胎干细胞作为移植组织的可再生来源的能力。小鼠胚胎肝脏是通过来自心脏中胚层的FGF信号从腹侧前肠内胚层诱导的。虽然我们越来越多地了解肝芽形成后调节成肝细胞增殖和分化的遗传途径,但将内胚层模式化与肝脏特化联系起来的早期事件尚不清楚。在非洲爪蟾,我们最近确定,差异Wnt/β-连环蛋白信号调节内胚层的命运。我们的数据支持一个模型,其中在原肠胚和早期体节阶段分泌的Wnt-拮抗剂在前内胚层建立前肠身份,并启动导致肝脏发育的分子级联反应。相反,后内胚层具有高β-连环蛋白活性,这是由于从侧/轴中胚层分泌的Wnt配体,其抑制前肠命运并促进肠发育。我们建议使用小鼠遗传学和胚胎外植体来测试这一假设,以表征潜在的分子机制。此外,我们将研究是否类似的途径是重要的肝脏发育在人类使用内胚层培养来自人胚胎干细胞。该提议的结果将直接影响产生用于治疗人类肝脏疾病的治疗有用的内胚层组织的努力。目标1。使用小鼠遗传学确定前内胚层中β-连环蛋白活性的抑制是否是前肠和肝脏发育所必需的。目标2.定义β-连环蛋白何时需要被抑制,并研究时间上不同的Wnt和FGF途径如何在肝脏发育过程中相互作用,使用小鼠胚胎外植体培养。目标3.研究Wnt信号传导在促进人类前肠和肝脏谱系来自HESC中的作用。公共卫生相关性。 肝脏是一个重要的器官,提供许多基本功能,许多疾病是如此危及生命,肝移植是唯一的选择。从胚胎干细胞分化的肝细胞是用于移植的组织的潜在可再生来源。这项计划的目的是阐明控制小鼠胚胎肝脏发育的遗传程序。然后,我们将利用这些信息来概括人类胚胎干细胞中的关键胚胎事件,以更有效地在培养中产生肝组织。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James M Wells其他文献

ヒトiPS細胞由来膵島オルガノイドのサイズ制御による効率的な分化誘導
通过控制人 iPS 细胞来源的胰岛类器官的大小进行有效分化诱导
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    浅見柚羽;草森浩輔;西川元也;James M Wells
  • 通讯作者:
    James M Wells
Mechanism and in vitro reconstruction of mammalian trachea-esophageal development
哺乳动物气管食管发育机制及体外重建
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lu Han;Praneet Chaturvedi;Keishi Kishimoto;Hiroyuki Koike;Talia Nasr;Kentaro Iwasawa;Kirsten Giesbrecht;Phillip C Witcher;Alexandra Eicher;Lauren Haines;Yarim Lee;John M Shannon;Mitsuru Morimoto;James M Wells;Takanori Takebe;Aaron M Zorn;Keishi Kishimoto
  • 通讯作者:
    Keishi Kishimoto

James M Wells的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James M Wells', 18)}}的其他基金

Project-3: Modeling EA/TEF in human organoids
项目 3:在人体类器官中模拟 EA/TEF
  • 批准号:
    10458162
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
Modeling esophageal/respiratory birth defects in human pluripotent stem cell (PSC)-derived fetal tissues
在人类多能干细胞 (PSC) 衍生的胎儿组织中模拟食管/呼吸系统出生缺陷
  • 批准号:
    10174986
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
Project-3: Modeling EA/TEF in human organoids
项目 3:在人体类器官中模拟 EA/TEF
  • 批准号:
    10647838
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
Human Endocrine Cell Development
人类内分泌细胞发育
  • 批准号:
    8814212
  • 财政年份:
    2012
  • 资助金额:
    $ 40.22万
  • 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
  • 批准号:
    8415736
  • 财政年份:
    2012
  • 资助金额:
    $ 40.22万
  • 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
  • 批准号:
    8516139
  • 财政年份:
    2012
  • 资助金额:
    $ 40.22万
  • 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
  • 批准号:
    8665593
  • 财政年份:
    2012
  • 资助金额:
    $ 40.22万
  • 项目类别:
Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
  • 批准号:
    8204678
  • 财政年份:
    2009
  • 资助金额:
    $ 40.22万
  • 项目类别:
Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
  • 批准号:
    7895193
  • 财政年份:
    2009
  • 资助金额:
    $ 40.22万
  • 项目类别:
Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
  • 批准号:
    7582986
  • 财政年份:
    2009
  • 资助金额:
    $ 40.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了